Breedlove Robert Charles — SEC Form 4 filings
SEC reporting owner CIK 2066645. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2025-05-21 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 2,677 shares, $26,804 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 1,692 shares @ $8.36 ($14,152) in Phathom Pharmaceuticals, Inc., filed 2025-07-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | Principal Accounting Officer | 9 | — | 3 legs · 2,677 sh · $26,804 | 9 |
Form 4 filings — Breedlove Robert Charles
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Tax withholding (F): 460 @ $9.05 | EDGAR |
| 2026-07-16 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Tax withholding (F): 1,555 @ $11.04 | EDGAR |
| 2026-03-03 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 13,000 @ $0 · Grant/award (A): 2,790 @ $0 · Tax withholding (F): 964 @ $12.56 · Tax withholding (F): 414 @ $12.56 | EDGAR |
| 2026-01-23 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Tax withholding (F): 776 @ $13.61 | EDGAR |
| 2025-12-19 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Tax withholding (F): 230 @ $16.28 | EDGAR |
| 2025-11-05 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 524 @ $13.51 | EDGAR |
| 2025-09-09 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 461 @ $12.09 | EDGAR |
| 2025-07-18 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 1,692 @ $8.36 | EDGAR |
| 2025-05-21 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2066645 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →